Lv1
56 积分 2024-11-12 加入
Bystander T cells in cancer immunology and therapy
13天前
已完结
Biomaterial-based scaffolds for direct in situ programming of tumor-infiltrating T lymphocytes
20天前
已完结
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer
1个月前
已完结
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF-κB pathway in canine mammary carcinoma cells
1个月前
已完结
Abstract LB400: Evolution of anti-viral and anti-tumor immunity in tumors in response to oncolytic virus therapy
3个月前
已关闭
A simple fluorescent labeling technique to study virus adsorption in Newcastle disease virus infected cells
3个月前
已完结
A simple fluorescent labeling technique to study virus adsorption in Newcastle disease virus infected cells
3个月前
已完结
WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment
3个月前
已关闭
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
3个月前
已完结
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
3个月前
已完结
皖公网安备34019202002308
